Levels of TNF-α are increased in sputum, bronchoalveolar lavage (BAL) fluid and serum of patients with COPD, which may further amplify the existing pulmonary inflammation and play a role in the systemic manifestations occurring in a subgroup of COPD patients [12,13]. Here, TNF is linked to chronic obstructive pulmonary disease.